Zhong Xiaoling, Ni Jun, Jia Zhijun, Yan Hong, Zhang Ying, Liu Yunyun
Department of Blood Transfusion, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Department of Clinical Laboratory, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
J Gastrointest Oncol. 2022 Feb;13(1):246-255. doi: 10.21037/jgo-22-97.
Metastasis is the major cause of colon adenocarcinoma (COAD) mortality. Increasing studies demonstrated that the epigenetics and downstream expression change of pivotal genes may act as a major role in promoting COAD progression and metastasis. Therefore, identifying the dysregulation of key genes associating with COAD metastasis may provide a new strategy for the discovery of potential treatment targets.
This study included a single-cell RNA sequencing profile consisting of 17,469 tumor cells derived from 23 samples, and 326 COADs available from The Cancer Genome Atlas (TCGA), etc. The study was performed using comparative analysis to characterize the role of in COAD metastasis and progression.
This study revealed that the mRNA level of Chromebox homolog 3 () in the metastatic COAD was significantly higher than that of the primary COAD and normal colon tissues (Wilcoxon's rank-sum test, P<0.05). Activation of was involved in regulating an interaction network consisting of , , and , etc., which may subsequently participate in glutathione metabolism. Besides, also exhibited a negative correlation with glycosphingolipid metabolism, which may associate with the regulation of CBX3 on DNA methylation. Clinical data analysis demonstrated that patients with high mRNA levels showed a nearly 2-fold shorter overall survival time than the control group (hazard ratio =1.59; likelihood ratio test, P=0.04).
Our study demonstrated that overexpression is associated with COAD metastasis. downstream regulation network involves in TCP1 complex, LSM family, and glutathione metabolism, which may provide a potential target for suppressing tumor metastasis.
转移是结肠腺癌(COAD)死亡的主要原因。越来越多的研究表明,关键基因的表观遗传学和下游表达变化可能在促进COAD进展和转移中起主要作用。因此,识别与COAD转移相关的关键基因的失调可能为发现潜在治疗靶点提供新策略。
本研究纳入了一个单细胞RNA测序图谱,该图谱由来自23个样本的17469个肿瘤细胞以及来自癌症基因组图谱(TCGA)等的326个COAD组成。本研究采用比较分析来表征[基因名称未给出]在COAD转移和进展中的作用。
本研究显示,转移性COAD中[基因名称未给出]的mRNA水平显著高于原发性COAD和正常结肠组织(Wilcoxon秩和检验,P<0.05)。[基因名称未给出]的激活参与调节由[其他基因名称未给出]等组成的相互作用网络,这可能随后参与谷胱甘肽代谢。此外,[基因名称未给出]与糖鞘脂代谢也呈负相关,这可能与CBX3对DNA甲基化的调节有关。临床数据分析表明,[基因名称未给出]mRNA水平高的患者总生存时间比对照组缩短近2倍(风险比=1.59;似然比检验,P=0.04)。
我们的研究表明,[基因名称未给出]过表达与COAD转移相关。[基因名称未给出]的下游调控网络涉及TCP1复合体、LSM家族和谷胱甘肽代谢,这可能为抑制肿瘤转移提供潜在靶点。